Brief Communication

Public Health

Kasmera 49(2):e49234108, Julio-Diciembre, 2021

P-ISSN 0075-5222   E-ISSN 2477-9628

https://doi.org/10.5281/zenodo.5515407

Congenital Syphilis in Ecuador is a still unsolved problem?

La sífilis congénita en Ecuador ¿un problema aún sin resolver?

González-Andrade Fabricio (Corresponding author). https://orcid.org/0000-0002-2091-9095. Universidad San Francisco de Quito. Colegio Ciencias de la Salud. Quito. Ecuador. Universidad Central del Ecuador. Facultad de Ciencias Médicas. Unidad de Medicina Traslacional. Quito. Ecuador. Dirección Postal: UnitIquique N14-121 y Sodiro-Itchimbía, Sector El Dorado, 170403, Quito. Ecuador. Telèfono: +593-9-984536414. E-mail: fabriciogonzaleza@gmail.com

Aguinaga-Romero Gabriela. https://orcid.org/0000-0002-6274-2195. Universidad San Francisco de Quito. Colegio Ciencias de la Salud. Quito. Ecuador.  E-mail: gabrielaaguinaga@yahoo.com

Carrero Yenddy. https://orcid.org/0000-0003-4050-4468. Universidad Técnica de Ambato. Facultad de Ciencias de la Salud. Carrera de Medicina. Ambato-Tungurahua. Ecuador. E-mail: yenddycarrero@yahoo.es

Ocaña Carolina. https://orcid.org/0000-0003-2432-9401. Universidad Central del Ecuador. Facultad de Ciencias Médicas. Unidad de Medicina Traslacional. Quito. Ecuador. E-mail: macaro.1791@gmail.com

Abstract

Congenital syphilis represents a public health problem. Despite the increases in prenatal care coverage, the actions implemented still show low effectiveness in their prevention. An epidemiological, observational, cross-sectional study is presented, in which data were obtained from the National Institute of Statistics and Censuses (INEC) with the purpose of establishing the current situation of congenital syphilis in Ecuador, taking into consideration the data throughout the last years. According to the registries, no cases of late syphilis have been reported for 6 years. The reports prior to 2004 are irregular, the data recorded from 2005 on are more reliable due to the mean and standard deviation data. There is a slight downward trend from 2003 to 2011 showing an increase of 200 reported cases in 2013. No detailed data was found as of 2016. Congenital syphilis still prevails, with a slightly higher prevalence in men, although the ratio (male / female) is kept at 1: 1. Since 2005 there is no significant variation. A downward slope is evident, but the mean values would indicate a plateau during the last 7 years. This fact will determine a blockage of the expected decrease in the number of cases. There is no proper official data record. The prevalence in Ecuador for the year 2019 shows 320 reported cases, but it remains stationary, with Guayas being the most affected province. The prevention, control and monitoring guidelines must be reviewed by the health authorities.

Keywords: syphilis, congenital, epidemiology, disease prevention.

Resumen

La sífilis congénita representa un problema de salud pública. A pesar de los incrementos en la cobertura de atención prenatal, las acciones implementadas aún exhiben baja efectividad en su prevención. Se presenta un estudio epidemiológico, observacional, transversal, en el cual se obtuvieron datos del Instituto Nacional de Estadística y Censos (INEC) con el propósito de establecer la situación actual de la sífilis congénita en el Ecuador tomando en consideración los datos a lo largo de los últimos años. De acuerdo con los registros no se han reportado casos de sífilis tardía desde hace 6 años. Los informes anteriores al año 2004 son irregulares, los datos registrados a partir de 2005 son más fiables debido a los datos de media y desviación estándar. Existe una ligera tendencia a la baja desde 2003 hasta 2011 que muestra un aumento de 200 casos notificados en 2013. No se encontraron datos detallados a partir del 2016. Aún existe predominio de sífilis congénita, con una prevalencia levemente mayor en los hombres, aunque la proporción (hombre / mujer) se mantiene en 1:1. Desde 2005 no hay una variación significativa. Se evidencia una pendiente descendente, pero los valores medios indicarían una meseta durante los últimos 7 años. Este hecho determinará un bloqueo del descenso esperado del número de casos. No existe un registro oficial de datos adecuado. La prevalencia en Ecuador para el año 2019 muestra 320 casos reportados, pero aún se mantiene estacionaria, siendo Guayas la provincia más afectada. Las directrices de prevención, control y seguimiento deben ser revisadas por las autoridades sanitarias.

Palabras claves: sífilis, sífilis congénita, epidemiología, prevención de enfermedades.

Recibido: 01/10/2020 | Aceptado: 30/05/2021 | Publicado: 20/09/2021

How to Cite: González-Andrade F, Aguinaga-Romero G, Carrero Y, Ocaña C. Congenital Syphilis in Ecuador is a still unsolved problem? Kasmera. 2021;49(2):e49234108. doi: 10.5281/zenodo.5515407

Introduction

Congenital syphilis (CS) is still a major public health problem, according to World Health Organization WHO (1). Researchers estimate that congenital syphilis is a complicating factor in about 1 million pregnancies every year worldwide. CS has a largely contributed toward infant death and has been responsible for 305,000 perinatal deaths worldwide annually (2).

While the prevalence of CS remains low in most developed countries, it has been a subtle remerging of the disease in some European countries including Spain, and South America. For 2006 in Latin America was overall reported 8.423 cases of CS, more than 164.000 children were born with CS in Latin American and Caribbean countries since 2007. By 2013 the overall reported cases were 13.831, Colombia reports 287.3 cases per 100,000 live births, Venezuela 4.6 cases per 100,000 live births, Argentina 99 cases per 100,000 live births, Honduras 14.7 cases per 100,000 live births, Cuba reports less than 2.4 by per 100,00 live births and Brazil 388.4 per 100,000 live births (3).

Despite the increase in prenatal care coverage in Ecuador, the actions implemented exhibit low effectiveness in its prevention (4). This disease without treatment, it is lethal (5). The disease can manifest according to severity, such as late abortion, stillbirth, and low birth weight. The first manifestations of syphilis in the neonatal period include aseptic meningitis, seizure, rash, and neonatal death. It can also manifest as a latent infection leading to subsequent sequel (6). Syphilis is a systemic an exclusive human sexually, sanguineous, and perinatal transmitted disease caused by the spirochete Treponema pallidum (7,8).

CS´s transmission occurs transplacentally at any time during gestation. The risk of transmission to the fetus depends on the stage of maternal infection. Usually, the longer before the pregnancy occurred the primary infection, the more benign the result regarding the rate and severity of infection. Untreated primary or secondary syphilis in pregnancy results in a 25% risk of stillborn, a 14% risk of neonatal death, a 41% risk of giving birth to a live but infected infant and only a 20% chance of giving birth to a healthy, uninfected infant (9). Cohort studies have been consistent in finding that substantial proportions (40 to 81%) of syphilis-exposed fetuses are severely affected, with stillbirth neonatal death being the most significant consequences (10).

However, fetal compromise is generally not manifested until later in the second or third trimesters with maturation of the fetal immune system (11). As syphilis remains an easily treatable disease, most cases of CS are seen in women who did not receive proper prenatal care or receive improper treatment. Treatment of early maternal syphilis at least 30 days before delivery is the most important factor influencing the risk of congenital infection. Seventy to 100 percent of infants born to untreated mothers will be infected compared to 1 to 2 percent of those born to women adequately treated during pregnancy (12).

WHO estimates most maternal syphilis infections are untreated and of sufficiently high-titer (RPR≥1: 8) (13) and 71 % of the syphilis diagnoses occurred when the patient requested care for symptoms (3). Routine screening of newborns sera or umbilical cord blood is not recommended, as diagnosis at this time does not prevent symptomatic congenital syphilis in some newborns (14). Effective prevention and detection of CS depends on the identification of syphilis in pregnant women and, therefore, on the routine serologic screening of pregnant women during the first prenatal visit. Additional testing at 28 weeks of gestation and again al the delivery is warranted for woman who increased risk or live-in communities with increased prevalence of syphilis infection (15). The mother has untreated syphilis, or the treatment is undocumented or inadequate (four weeks before delivery or with any nonpenicillin G regimen), a complete evaluation consisting of cerebrospinal fluid analysis, long bone radiographs, and complete blood cell and platelet counts should be performed to guide optimal therapy (16).

However, infection rates are shown also among women, especially pregnant women. This group needs special attention due to the importance for the incidence and the prevalence of congenital syphilis. Active syphilis in pregnant women presents fetal or perinatal death and serious neonatal infection. CS elimination as a public health problem will be achieved through reduction on prevalence of syphilis of pregnant women and reducing mother to child transmission of syphilis (17). The economic burden associated with the treatment of CS affects not only families, but society. The hospitalization cost for an infant affected by CS is as much as 7 times higher, and the length of hospital stay is approximately 8 days longer than for a healthy infant. These cost increase estimates do not include post discharge medical expenses related to late CS.  In comparison, prenatal screening offers a long-term cost-benefit for public health entities (18).

In this paper, it analyzes the prevalence of the disease in Ecuador through the time, to set the evolution and the situation of the same, and its implications to reduce child mortality through reductions in perinatal deaths and low-birth-weight infants.

Methods

Study design: epidemiological, observational, and cross-sectional study.

Data source: National Census and Statistics Institute (INEC) of Ecuador. Data was obtained from birth, annual reports, death reports and hospital bed occupation, during the years 2000 to 2016. The statistics are of national, urban, rural, regional, provincial, cantonal, and parochial coverage. The information was collected in all the establishments that provide hospitalization at the national level and the patients diagnosed according to the clinical and laboratory parameters were taken into consideration.

Specific methods: it used an information collection sheet, to gather all information required.

Statistical analysis: data collection, analysis and evaluation were collected in an Excel database to be analyzed with the SPSS© software version 22, licensed; appropriate descriptive statistics were used for the analysis.

Avoided biases: it was verified that all the information was complete; the information was always collected by the same operator.

Limitations: being a purely descriptive work based on databases, there were limitations such as, for example, validating the cases individually with the patient directly to confirm the diagnosis, it could not fully establish if there were cases of re-admissions even when each of the cases was verified through clinical records, and there is a general sub-registry in the country that could vary the study.

Ethical criteria: no approval was required. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (19).

Result

It analyzed 2701 cases corresponding to Congenital Syphilis (CS), Early Syphilis (ES), Late Syphilis (LS) and other types of Syphilis (OS) according to the ICD 10, during the years 2000 to 2016. The annual average of cases reported with CS was 124.12 (SD 42.41), ES 11.41 (SD 8.10), LS 10.47 (SD 12.50), and finally, OS 12.88 (SD 6.49). Distribution of cases of CS between 2000 and 2003 shows an increase of 43.38 cases per year with an average of 167.5 cases reported in four years, similar to the period 2012 to 2016 with an average of 150.8 cases per year and an increase of 26.68 cases during that period. The highest rate of reported cases of CS was 59.45 cases per 100,000 live births in 2013 (Table 1). The provinces of Pichincha and Guayas show most reported cases to be provinces of national reference; however, the province of Los Rios also reports a significant increase with 31 cases of CS in 2002, with an average of 19 cases per year compared with other provinces. Some data indicate that during the years 2017 and 2018 of every 293,139 and 291.39 live births, 261 and 129 cases were diagnosed, respectively (data not revealed).

Table 1. Syphilis infection prevalence in Ecuador (2000-2016)

Year

Congenital Syphilis

Early Syphilis

Late Syphilis

Other Syphilis

Total

N

%

Rate

n

%

Rate

n

%

Rate

N

%

Rate

2016

117

55.18

36.70

14

6.60

4.39

13

5.38

4.00

6

2.83

1.88

150

2015

140

66.03

43.92

26

12.26

8.15

29

12.01

8.92

8

3.77

2.50

203

2014

155

73.11

48.63

27

12.74

8.47

0

0.00

0.00

30

14.15

9.41

212

2013

193

80.08

59.45

24

9.96

7.39

9

3.73

2.77

15

6.22

4.62

241

2012

149

81.87

43.17

16

8.79

4.64

12

6.59

3.48

5

2.75

1.45

182

2011

72

77.42

20.70

6

6.45

1.73

0

0.00

0.00

15

16.13

4.31

93

2010

87

86.14

24.75

8

7.92

2.28

0

0.00

0.00

6

5.94

1.71

101

2009

84

80.77

23.25

7

6.73

1.94

0

0.00

0.00

13

12.50

3.60

104

2008

118

83.69

31.92

5

3.55

1.35

0

0.00

0.00

18

12.77

4.87

141

2007

74

72.55

20.02

6

5.88

1.62

0

0.00

0.00

22

21.57

5.95

102

2006

71

78.89

20.60

8

8.89

2.32

0

0.00

0.00

11

12.22

3.19

90

2005

81

73.64

25.34

9

8.18

2.82

13

11.82

4.07

7

6.36

2.19

110

2004

99

55.62

32.39

19

10.67

6.22

46

25.84

15.05

14

7.87

4.58

178

2003

192

83.12

57.68

9

3.90

2.70

15

6.49

4.51

15

6.49

4.51

231

2002

157

83.07

49.91

3

1.59

0.95

20

10.58

6.36

9

4.76

2.86

189

2001

172

88.21

51.69

4

2.05

1.20

10

5.13

3.01

9

4.62

2.70

195

2000

149

83.24

43.10

3

1.68

0.87

11

6.15

3.18

16

8.94

4.63

179

Mean

SD

 

Mean

SD

 

Mean

SD

Mean

SD

Mean

124.12

42.41

 

11.41

8.10

 

10.47

12.50

12.88

6.49

158.88

Rate calculated by 100.000 live births

Data source: INEC

Overall prevalence in male reported was 50.45% and female 49.54%.

SD: standard deviation

The global predominance of syphilis is attributed to the male population. In general, statistics within CS syphilis group men appear with greater prevalence. Nevertheless, this is not decisive. There is the need to observe data during the years 2001, 2004, 2005, 2010 and 2011. During those years female prevalence is shown (Table 2). Some records indicate that during 2017, 69 cases of congenital syphilis were diagnosed in males and 60 in females, while in 2018 the figure increased to 142 cases of congenital syphilis in males and 119 in females.

Table 2.  Sex distribution of Syphilis in Ecuador (2000-2016)

  

 

Congenital Syphilis

Early Syphilis

Late Syphilis

Other Syphilis

 

Men

n= (%)

Women n= (%)

Total

Men

n= (%)

Women n= (%)

Total

Men

n= (%)

Women n= (%)

Total

Men

n= (%)

Women n= (%)

Total

Total

958 (51.70)

895 (48.30)

1853

81 (52.60)

73 (47.40)

154

62 (44.93)

76 (55.07)

138

112 (52.58)

101 (47.42)

213

Mean

64.35

59.76

124.11

5.40

4.87

10.27

4.13

5.07

9.2

7.467

6.73

14.2

SD

23.73

20.14

45.10

3.79

4.47

7.61

5.04

7.41

12.32

4.44

3.61

7.08

Regarding the prevalence first years of registry (2000 to 2003) shows cases as higher as the end of the baseline (2012 to 2016) (Figure 1).

Figure1. Cases distribution by year

Discussion

Prevalence of CS is higher over the rest of groups showed early, late, and other forms of syphilis. This fact was due to lack of prevention around those years in Ecuador. Records presented in year 2008 have a peak that should be analyzed considering the way of registry. Presence of false positive could be questioned due to new diagnostic technics. There should be special attention to the fact data was reviewed over 12 years, 2000 to 2016. This range of time could have higher dispersion of cases number. Statistics analysis of the mean values compared with standard deviation data supports greater reliability of registry from year 2005 (Figure 1).

Since 2006 and forward no report of late syphilis was made. That finding could mean progression of the illness has been stopped giving those records are persistent. That would be ideal, but there is the possibility the cases have been registered somewhere else like other syphilis. In that scenario it would not show diminished prevalence. Other syphilis refers to all survival people who have had illness control. Those people have regular follow up by health personnel. It has not been established if cases presented belong just to people who have been born in Ecuador or come from another country. This is a circumstance that must be presented because of recent immigration to Ecuador (20).

The global predominance of syphilis is attributed to the male population, however the female population stood out in other years. This finding reproduces the analysis of late syphilis until 2005. Considering the previous discussion on reliability, no one can be made. Categorical statement about a higher prevalence. In general terms, although the number of cases in men is higher, the ratio is almost 1: 1 for both sexes (21). Prevalence in Ecuador regarding to male/female ratio is about the same as published by other countries. In Colombia, in 2020, 777 cases of congenital syphilis were registered, representing an increase of 19% compared to the previous year, with 192 cases of patients from or residents of Venezuela (22). In 2018 in Peru the incidence of congenital syphilis ranged from 0.3 to 0.5 cases per 1000 live births (23); in 2019, an incidence of congenital syphilis (including stillbirths) was reported at 0.5 cases or less per 1000 live births, however there are no detailed official data available in recent years.

Most common cause of CS is a deficiency of pregnancy control.  Even in largest cities some women do not access to an adequate medical control during pregnancy. Those who get attention not always have the number of medical controls required (24). There is educational factor involved also related with a low impact in the strategies to accomplish the standards of care. Venereal Disease Research Laboratory (VDRL) is not always performed during pregnancy (25).

The number of cases has an irregular tendency downward. However, analysis made covers 12 years of reports with shortcoming about information and registry. If only statistically reliably data is considered, variation from year 2005 is not significant. It maintains a slight slope declined but media values presented would indicate a plateau during last 7 years. Considerations previously explained should be taken for year 2008 data. The data obtained confirm the proposed plateau on syphilis in Ecuador. Despite the fact that the absolute number of cases has presented an annual rate of decrease in prevalence, it has not undergone such a change in recent years (26).

This determines a blockage on expected descent of cases. Real effectiveness of existing prevention and treatment of congenital syphilis programs is questionable. Possibly, there is not yet adequate follow up of all pregnant women. Perhaps, follow up by health professionals is still deficient (27). Reasons to explain the unchanged prevalence during specially the last 8 years are initially due to lack of adequate registry of data (28). There are still some ethnic groups as Native Amerindians, poverty, and lack of enough education, to whom information regarding sexual education and pregnancy control is still insufficient (29). Other problem is the health promotion is not well understood. To assure prevention, there is a need of better planning and management in public health. Physicians, nurses, medical students, and people related to health system should be involved. Authorities should have a program and monitor its effectiveness (30).

There are many physicians who still gather only at the main hospitals. If the goal to lower cases of syphilis is based on prevention the work remaining will not be at the hospital only. There should be emphasis to go out, educate and make sure it has had an impact on target population. Coordination will be expected from health authorities (31). CS registry requires background research, clinical abilities to detect characteristic signs and symptoms and adequate diagnosis tests opportunely (32).

Cases reported and presented by the INEC are official. Data is approved by the Ecuadorian government. It was possible to find archives from year 2000 giving that previous information is not complete. Archives in some cases have been eliminated from the virtual database. Although there is some information published in other papers even in Ecuador, only records part of national reference has been taken in consideration for this paper. The rate of CS in the United States reached a low of 8.4 cases per 100.000 live births in 2012 compared with our study Ecuador CS rate was 43.17 cases per 100.000 live births for the same year. In Ecuador, there have been reports on the number of cases in different publications. There are some variations in the numbers presented here. Causes to find some cases which do not coincide with different sources researched can be explained by and inadequate registry of cases or misreport in official sources. Nonetheless, data maintain stated distribution. It is due to this reason analysis don´t vary overall, albeit it could show variations from the statistical point of view (33).

In September 2010, WHO member countries in the region of the Americas approved the Strategy a Plan of Action for Elimination of Mother-to-Child Transmission of HIV and Congenital Syphilis in the Americas (resolution 50/12. 50 Directive Council Meeting); the proposed goals until 2015 were (i) to reduce HIV maternal-to-child transmission to 2% or less (ii) to reduce the incidence of pediatric HIV cases to 0.3 or less per 1000 live births; and (iii) to reduce congenital syphilis incidence including stillbirths) to 0.5 or less per 1000 live births until 2015 (34).

In 2007 the WHO launched a global initiative for the elimination of CS. Furtherly. WHO estimated that in countries with high antenatal syphilis burden allowed to focus efforts in strengthening existing maternal and child health systems infrastructure, an small investment could substantially reduce this global perinatal scourge. Elimination of CS requires a combined commitment of governments and other partners to mount an effective and sustained response (35,36).

WHO has outlined a strategic plan of action for the global elimination of CS is a public health problem. The four-pillar strategy for elimination CS is ensure advocacy and sustained political commitment for a successful health initiative, increase access to, and quality of maternal and newborn health services, screen and treat pregnant women and partners, and establish surveillance, monitoring, and evaluation systems (37).

The global initiative emphasizes that congenital syphilis elimination can contribute directly to three of the Millennium Development Goals by reducing child mortality through reductions in perinatal deaths and low-birth-weight infants; improving maternal health through reductions in late fetal losses and stillbirths and through a decreased burden of syphilis in pregnant women, and combating HIV/AIDS, malaria and other diseases through combined systematic screening for HIV and syphilis in pregnancy with an emphasis on strengthening antenatal and postpartum health systems (12).

Unfortunately, Ecuador is far of this reality. Several barriers currently exist that limit maternal syphilis screening and treatment efforts (38). Promote maternal syphilis screening and treatment as part of basic antenatal health services its mandatory (39). In addition, promotes strategies such as incorporating integrated professional training and curricula for health care providers or integrating data systems monitoring (40) it will support to build capacities and it will improve antenatal outcomes.

Current prevalence of CS in Ecuador shows a slight drop, but it is still stationary. Prevention, control and follow up guidelines must be reviewed by health authorities in Ecuador. Standard of care must be known by patients and health personnel. Ecuador will probably not reach the millennium development goals if syphilis remains stationary.

Acknowledgements

The authors are grateful to the researchers and health authorities that support this initiative.

Conflict of Relations and Activities

The authors declare not to present conflicts of interest and relationships during the conduct of the study.

Funding

The research was carried out with the researchers' own funds; therefore, it was self-financed.

Referencias Bibliográficas

1.      Onesimo R, Buonsenso D, Gioè C, Valetini P. Congenital syphilis: remember to not forget. BMJ Case Rep [Internet]. 2012;2012:bcr0120125597. Disponible en: http://casereports.bmj.com/content/2012/bcr.01.2012.5597.abstract DOI: 10.1136/bcr.01.2012.5597 PMID 22669017 PMCID PMC3369312

2.      Hussain SA, Vaidya R. Congenital Syphilis [Internet]. StatPearls. StatPearls Publishing; 2021 [citado 10 de agosto de 2020]. p. 143-61. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK537087/ PMID 30725772

3.      Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. Morb Mortal Wkly Rep [Internet]. 2015;64(RR-03):1-137. Disponible en: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm PMID 26042815 PMCID PMC5885289

4.      Araújo CL de, Shimizu HE, Sousa AIA de, Hamann EM. Incidence of congenital syphilis in Brazil and its relationship with the Family Health Strategy. Rev Saude Publica [Internet]. 2012;46(3):479-86. Disponible en: https://www.scielo.br/j/rsp/a/SzWDZTVcgztjhcxgYVb75Ky/?lang=en DOI: 10.1590/s0034-89102012000300010 PMID 22635036

5.      Kwan KSH, Giele CM, Greville HS, Reeve CA, Lyttle PH, Mak DB. Syphilis epidemiology and public health interventions in Western Australia from 1991 to 2009. Sex Health [Internet]. 2012;9(3):272-9. Disponible en: https://doi.org/10.1071/SH11102 DOI: 10.1071/SH11102 PMID 22697145

6.      Oloya S, Lyczkowski D, Orikiriza P, Irama M, Boum Y, Migisha R, et al. Prevalence, associated factors and clinical features of congenital syphilis among newborns in Mbarara hospital, Uganda. BMC Pregnancy Childbirth [Internet]. 2020;20(1):385. Disponible en: https://doi.org/10.1186/s12884-020-03047-y DOI: 10.1186/s12884-020-03047-y PMID 32616037 PMCID PMC7330944

7.      Ortiz-Lopez N, Diez M, Diaz O, Simon F, Diaz A. Epidemiological Surveillance of Congenital Syphilis in Spain, 2000–2010. Pediatr Infect Dis J [Internet]. 2012;31(9):988-90. Disponible en: https://journals.lww.com/pidj/Fulltext/2012/09000/Epidemiological_Surveillance_of_Congenital.33.aspx. DOI: 10.1097/inf.0b013e31825d3152 PMID 22572752

8.      Keuning MW, Kamp GA, Schonenberg-Meinema D, Dorigo-Zetsma JW, van Zuiden JM, Pajkrt D. Congenital syphilis, the great imitator-case report and review. Lancet Infect Dis [Internet]. 2020;20(7):e173-9. Disponible en: https://doi.org/10.1016/S1473-3099(20)30268-1 DOI: 10.1016/S1473-3099(20)30268-1 PMID 32502432

9.      Arnold SR, Ford-Jones EL. Congenital syphilis: A guide to diagnosis and management. Paediatr Child Health [Internet]. 2000;5(8):463-9. Disponible en: https://doi.org/10.1093/pch/5.8.463 DOI: 10.1093/pch/5.8.463 PMID 20177559 PMCID PMC2819963

10.    Mabey D, Peeling RW. Syphilis, still a major cause of infant mortality. Lancet Infect Dis [Internet]. 2011;11(9):654-5. Disponible en: https://doi.org/10.1016/S1473-3099(11)70150-5 DOI: 10.1016/S1473-3099(11)70150-5 PMID 21683654

11.    Bowen V, Su J, Torrone E, Kidd S, Weinstock H. Increase in incidence of congenital syphilis - United States, 2012-2014. Morb Mortal Wkly Rep [Internet]. 2015;64(44):1241-5. Disponible en: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6444a3.htm DOI: 10.15585/mmwr.mm6444a3 PMID 26562206

12.    Kamb ML, Newman LM, Riley PL, Mark J, Hawkes SJ, Malik T, et al. A Road Map for the Global Elimination of Congenital Syphilis. Obstet Gynecol Int [Internet]. 2010;2010:312798. Disponible en: https://doi.org/10.1155/2010/312798 DOI: 10.1155/2010/312798 PMID 20706693 PMCID PMC2913802

13.    Pan American Health Organization. Regional iniciative for the elimination of mother-to-child transmission of HIV and congenital syphilis in Latin America and the Caribbean: regional monitoring strategy 2010 [Internet]. Washington DC-USA: Pan American Health Organization; 2010. Disponible en: https://iris.paho.org/handle/10665.2/9992

14.    Masarweh K, Horovitz Y, Avital A, Spiegel R. Establishing hospital admission criteria of pediatric Henoch–Schonlein purpura. Rheumatol Int [Internet]. 2014;34(11):1497-503. Disponible en: https://doi.org/10.1007/s00296-014-2971-9 DOI: 10.1007/s00296-014-2971-9 PMID 24563020

15.    Cooper JM, Sánchez PJ. Congenital syphilis. Semin Perinatol [Internet]. 2018;42(3):176-84. Disponible en: https://www.sciencedirect.com/science/article/pii/S0146000518300119 DOI: 10.1053/j.semperi.2018.02.005 PMID 29627075

16.    Arnesen L, Martínez G, Mainero L, Serruya S, Durán P. Gestational syphilis and stillbirth in Latin America and the Caribbean. Int J Gynecol Obstet [Internet]. 2015;128(3):241-5. Disponible en: https://doi.org/10.1016/j.ijgo.2014.09.017 DOI: 10.1016/j.ijgo.2014.09.017 PMID 25443140

17.    Rowe CR, Newberry DM, Jnah AJ. Congenital Syphilis: A Discussion of Epidemiology, Diagnosis, Management, and Nurses’ Role in Early Identification and Treatment. Adv Neonatal Care [Internet]. 2018;18(6):438-45. Disponible en: https://journals.lww.com/advancesinneonatalcare/Fulltext/2018/12000/Congenital_Syphilis__A_Discussion_of_Epidemiology,.5.aspx DOI: 10.1097/anc.0000000000000534 PMID 30020089

18.    Center for Diseases Control and Prevention. Sífilis - Enfermedades de transmisión sexual [Internet]. Disponible en: https://www.cdc.gov/std/spanish/sifilis/stdfact-syphilis-s.htm

19.    Asociación Médica Mundial. Declaración de Helsinki de la AMM – Principios éticos para las investigaciones médicas en seres humanos [Internet]. 2017. p. 1-3. Disponible en: https://www.wma.net/es/policies-post/declaracion-de-helsinki-de-la-amm-principios-eticos-para-las-investigaciones-medicas-en-seres-humanos/

20.    Cáceres K. Situación epidemiológica de sífilis (CIE 10: A50-A53.9). Chile, 2016. Rev Chil Infectología [Internet]. 2018;35(3):284-96. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182018000300284&lng=en&nrm=iso&tlng=en DOI: 10.4067/s0716-10182018000300284 PMID 30020089

21.    DiOrio D, Kroeger K, Ross A. Social Vulnerability in Congenital Syphilis Case Mothers: Qualitative Assessment of Cases in Indiana, 2014 to 2016. Sex Transm Dis [Internet]. 2018;45(7):447-51. Disponible en: https://journals.lww.com/stdjournal/Fulltext/2018/07000/Social_Vulnerability_in_Congenital_Syphilis_Case.3.aspx DOI: 10.1097/OLQ.0000000000000783 PMID 29465662 PMCID PMC5995623

22.    Instituto Nacional de Salud. Comportamiento de sífilis gestacional y sífilis congénita, Colombia a período epidemiológico VII 2020. Semana epidemiológica 30 [Internet]. Boletín Epidemiológico Semanal. 2020. Disponible en: https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2020_Boletin_epidemiologico_semana_30.pdf DOI: 10.33610/23576189.2020.30

23.    Centro Nacional de Epidemiología Prevención y Control de Enfermedades, Ministerio de Salud Pública. Boletín epidemiológico del Perú. Volumen 27-SE 32 [Internet]. 2018. Disponible en: https://www.dge.gob.pe/portal/docs/vigilancia/boletines/2018/32.pdf

24.    Torres RG, Mendonça ALN, Montes GC, Manzan JJ, Ribeiro JU, Paschoini MC. Syphilis in Pregnancy: The Reality in a Public Hospital. Rev Bras Ginecol Obs [Internet]. 2019;41(02):90-6. Disponible en: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0038-1676569 DOI: 10.1055/s-0038-1676569 PMID 30786305

25.    Arévalo Castro OR, Suárez Pérez Y. Detection of syphilis by a serological method in pregnant women from Guayaquil City. Rev Cuba Investig Biomed [Internet]. 2015;34(3):224-36. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=63992

26.    Lazarini FM, Barbosa DA. Educational intervention in Primary Care for the prevention of congenital syphilis. Rev Lat Am Enfermagem [Internet]. 2017;25:e2845. Disponible en: https://www.scielo.br/j/rlae/a/gjqXpt8vnSRY8cKFtgKMDbq/?lang=en# DOI: 10.1590/1518-8345.1612.2845 PMID 28146181 PMCID PMC5288867

27.    Díaz J. Vigilancia epidemiológica de sífilis y gonorrea. Rev Chil Infectol [Internet]. 2013;30(3):303-10. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-10182013000300005&lng=en&nrm=iso&tlng=en DOI: 10.4067/S0716-10182013000300005 PMID 23877778

28.    Domingues RMSM, Lauria L de M, Saraceni V, Leal M do C. Treatment of syphilis during pregnancy: knowledge, practices and attitudes of health care professionals involved in antenatal care of the Unified Health System (SUS) in Rio de Janeiro City. Cien Saude Colet [Internet]. 2013;18(5):1341-51. Disponible en: https://www.scielo.br/j/csc/a/k9Yfc5MdkSYCfBr6GFmpsVg/?lang=pt DOI: 10.1590/S1413-81232013000500019 PMID 23670462

29.    Hogben M, Collins D, Hoots B, O’Connor K. Partner Services in Sexually Transmitted Disease Prevention Programs: A Review. Sex Transm Dis [Internet]. 2016;43(2-S1):S53-62. Disponible en: https://journals.lww.com/stdjournal/Fulltext/2016/02001/Partner_Services_in_Sexually_Transmitted_Disease.8.aspx DOI: 10.1097/olq.0000000000000328 PMID 26779688 PMCID PMC4717997

30.    Institute of Medicine (US) Committee on Health Research and the Privacy of Health Information: The HIPAA Privacy Rule. The Value, Importance, and Oversight of Health Research. En: Nass S, Levit L, Gostin L, editores. Beyond the HIPAA Privacy Rule: Enhancing Privacy, Improving Health Through Research [Internet]. Washington DC-USA: National Academies Press (US); 2009. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK9571

31.    AngelMüller E, GrilloArdila CF, AmayaGuio J, TorresMontañez NA, VasquezVelez LF. Point of care rapid test for diagnosis of syphilis infection in men and nonpregnant women. Cochrane Database Syst Rev [Internet]. 2018;2018(5):CD013036. Disponible en: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013036/full DOI: 10.1002/14651858.CD013036 PMCID PMC6494531

32.    Centers for Disease Control and Prevention. STD Facts - Syphilis [Internet]. 2021. Disponible en: https://www.cdc.gov/std/hiv/stdfact-std-hiv.htm

33.    Ortiz-Prado E, Castillo TA, Olmedo-López M, Armijos L, Ramírez D, Iturralde AL. Cesarean section rates in Ecuador: A 13-year comparative analysis between public and private health systems. Rev Panam Salud Publica [Internet]. 2017;41:1-7. Disponible en: https://iris.paho.org/handle/10665.2/33845?locale-attribute=pt DOI: 10.26633/RPSP.2017.15 PMID 31391814 PMCID PMC6660865

34.    Pan American Health Organization. Strategy and Plan of Action for Elimination of Mother-to-Child Transmission of HIV and Congenital Syphilis [Internet]. 2010. Disponible en: https://iris.paho.org/handle/10665.2/4846

35.    Hossain M, Broutet N, Hawkes S. The Elimination of Congenital Syphilis: A Comparison of the Proposed World Health Organization Action Plan for the Elimination of Congenital Syphilis With Existing National Maternal and Congenital Syphilis Policies. Sex Transm Dis [Internet]. 2007;34(7 Suppl):S22-30. Disponible en: https://journals.lww.com/stdjournal/Fulltext/2007/07001/The_Elimination_of_Congenital_Syphilis__A.5.aspx DOI: 10.1097/01.olq.0000261049.84824.40 PMID 17592387

36.    Newman L, Kamb M, Hawkes S, Gomez G, Say L, Seuc A, et al. Global Estimates of Syphilis in Pregnancy and Associated Adverse Outcomes: Analysis of Multinational Antenatal Surveillance Data. PLOS Med [Internet]. 2013;10(2):e1001396. Disponible en: https://doi.org/10.1371/journal.pmed.1001396 DOI: 10.1371/journal.pmed.1001396 PMID 23468598 PMCID PMC3582608

37.    World Health Organization. The Global elimination of congenital syphilis: rationale and strategy for action [Internet]. Geneve-Switzerland: World Health Organization; 2007. Disponible en: http://whqlibdoc.who.int/publications/2007/9789241595858_eng.pdf?ua=1.

38.    Nkamba D, Mwenechanya M, Kilonga AM, Cafferata ML, Berrueta AM, Mazzoni A, et al. Barriers and facilitators to the implementation of antenatal syphilis screening and treatment for the prevention of congenital syphilis in the Democratic Republic of Congo and Zambia: results of qualitative formative research. BMC Health Serv Res [Internet]. 2017;17(1):556. Disponible en: https://doi.org/10.1186/s12913-017-2494-7 DOI: 10.1186/s12913-017-2494-7 PMID 28807019 PMCID PMC5556622

39.    Kanyangarara M, Walker N, Boerma T. Gaps in the implementation of antenatal syphilis detection and treatment in health facilities across sub-Saharan Africa. PLoS One [Internet]. 2018;13(6):e0198622. Disponible en: https://doi.org/10.1371/journal.pone.0198622 DOI: 10.1371/journal.pone.0198622 PMID 29856849 PMCID PMC5983468

40.    Institute of Medicine (US) Committee on the Health Professions Education Summit. The Core Competencies Needed for Health Care Professionals. En: Greiner AC, Knebel E, editors. Health Professions Education: A Bridge to Quality. Washington (DC): National Academies Press (US); 2003. Chapter 3. Available from: https://www.ncbi.nlm.nih.gov/books/NBK221519/

Authors' Contribution

GAF, ARG, CY and OC: conceptualization, methodology, validation, formal analysis, investigation, resources, data curation, drafting-preparation of the original draft, writing-review and editing, visualization, supervision, planning and execution, project administration, funding acquisition

 

©2021. Los Autores. Kasmera. Publicación del Departamento de Enfermedades Infecciosas y Tropicales de la Facultad de Medicina. Universidad del Zulia. Maracaibo-Venezuela. Este es un artículo de acceso abierto distribuido bajo los términos de la licencia Creative Commons atribución no comercial (https://creativecommons.org/licenses/by-nc-sa/4.0/) que permite el uso no comercial, distribución y reproducción sin restricciones en cualquier medio, siempre y cuando la obra original sea debidamente citada.